These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


225 related items for PubMed ID: 11929445

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The impact of olanzapine on tardive dyskinetic symptoms in a state hospital population.
    Brar JS, Parepally H, Chalasani L, Gopalani A, Appel N, Chengappa KN.
    Ann Clin Psychiatry; 2008; 20(3):139-44. PubMed ID: 18633740
    [Abstract] [Full Text] [Related]

  • 4. Incidence of tardive dyskinesia in first-episode psychosis patients treated with low-dose haloperidol.
    Oosthuizen PP, Emsley RA, Maritz JS, Turner JA, Keyter N.
    J Clin Psychiatry; 2003 Sep; 64(9):1075-80. PubMed ID: 14628983
    [Abstract] [Full Text] [Related]

  • 5. The effects of clozapine on tardive dyskinesia.
    Lieberman JA, Saltz BL, Johns CA, Pollack S, Borenstein M, Kane J.
    Br J Psychiatry; 1991 Apr; 158():503-10. PubMed ID: 1675900
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clozapine treatment of psychosis in patients with tardive dystonia: report of three cases.
    Friedman JH.
    Mov Disord; 1994 May; 9(3):321-4. PubMed ID: 7913739
    [Abstract] [Full Text] [Related]

  • 9. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol.
    Tollefson GD, Beasley CM, Tamura RN, Tran PV, Potvin JH.
    Am J Psychiatry; 1997 Sep; 154(9):1248-54. PubMed ID: 9286184
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prospective study of tardive dyskinesia in the elderly: rates and risk factors.
    Woerner MG, Alvir JM, Saltz BL, Lieberman JA, Kane JM.
    Am J Psychiatry; 1998 Nov; 155(11):1521-8. PubMed ID: 9812112
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Utility of quetiapine in tardive dyskinesia].
    Navarro Pacheco BV, Montejo González AL, Martín Carrasco M.
    Actas Esp Psiquiatr; 2003 Nov; 31(6):347-52. PubMed ID: 14639511
    [Abstract] [Full Text] [Related]

  • 15. Tardive dyskinesia in affective disorders.
    Kane JM.
    J Clin Psychiatry; 1999 Nov; 60 Suppl 5():43-7; discussion 48-9. PubMed ID: 10192407
    [Abstract] [Full Text] [Related]

  • 16. Effects of antipsychotic treatment on tardive dyskinesia: a 6-month evaluation of patients from the European Schizophrenia Outpatient Health Outcomes (SOHO) Study.
    Tenback DE, van Harten PN, Slooff CJ, Belger MA, van Os J, SOHO Study Group.
    J Clin Psychiatry; 2005 Sep; 66(9):1130-3. PubMed ID: 16187770
    [Abstract] [Full Text] [Related]

  • 17. Tardive dyskinesia and informed consent: myths and realities.
    Munetz MR, Roth LH, Cornes CL.
    Bull Am Acad Psychiatry Law; 1982 Sep; 10(2):77-88. PubMed ID: 6129012
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Screening for tardive dyskinesia.
    Munetz MR, Schulz SC.
    J Clin Psychiatry; 1986 Feb; 47(2):75-7. PubMed ID: 2867994
    [Abstract] [Full Text] [Related]

  • 20. Fluctuation of tardive dyskinesia.
    Caligiuri MP, Lohr JB, Vaughan RM, McAdams LA.
    Biol Psychiatry; 1995 Sep 01; 38(5):336-9. PubMed ID: 7495929
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.